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Developmental Hedgehog signaling controls prolif-
eration of cerebellar granule cell precursors (GCPs),
and its aberrant activation is a leading cause of me-
dulloblastoma. We show here that Hedgehog pro-
motes polyamine biosynthesis in GCPs by engaging
a non-canonical axis leading to the translation of
ornithine decarboxylase (ODC). This process is
governed by AMPK, which phosphorylates threonine
173 of the zinc finger protein CNBP in response
to Hedgehog activation. Phosphorylated CNBP in-
creases its association with Sufu, followed by
CNBP stabilization, ODC translation, and polyamine
biosynthesis. Notably, CNBP, ODC, and polyamines
are elevated in Hedgehog-dependent medulloblas-
toma, and genetic or pharmacological inhibition of
this axis efficiently blocks Hedgehog-dependent
proliferation of medulloblastoma cells in vitro and
in vivo. Together, these data illustrate an auxiliary
mechanism of metabolic control by a morphogenic
pathway with relevant implications in development
and cancer.
INTRODUCTION
The Sonic Hedgehog (Shh) pathway is a critical regulator of
embryonic patterning and post-natal stem or progenitor cells
(Northcott et al., 2012a). In the cerebellum, Shh promotes the
post-natal mitotic expansion of cerebellar granule progenitors
(GCPs) (Wechsler-Reya and Scott, 1999) and the aberrant acti-
vation of the signaling in these cells is a leading cause of medul-Develoblastoma (MB) (Schu¨ller et al., 2008; Yang et al., 2008), the
most frequent brain malignancy of the childhood.
Shh ligand binds to themembrane inhibitory receptor Patched
(Ptch), thus alleviating its inhibitory activity upon the transmem-
brane transducer Smoothened (Smo). These events occur at the
primary cilium and trigger a cascade of intracellular processes
that involve the dynamic association between the Gli transcrip-
tion factors (Gli1, Gli2, and Gli3) and Sufu, which in turn regulates
their activity, processing, and cellular localization (Ryan and
Chiang, 2012).
The aberrant activation of Shh pathway observed in MB can
been attributed tomutations or amplifications of genes encoding
pathway components, such as Ptch, Smo, Sufu, and Gli2 or
other mechanisms (Schroeder and Gururangan, 2014).
Different small molecule inhibitors of the Shh signaling have
been generated and tested, thus providing hope to MB patients.
However, the majority of these compounds inhibits Smo activity
and is thus inactive in case of mutations occurring at the down-
stream level. Additionally, trials in patients and animals with tu-
mors driven by mutations of Ptch or Smo have shown that,
despite a good initial response, they quickly develop resistance.
For these reasons, it is nowbelieved that alternative approaches,
preferably targeting downstream components of the signaling,
are required (Di Magno et al., 2015).
Polyamines are small intracellular polycations that control key
aspects of cell biology, such as cell replication, translation, cell
growth, differentiation, and survival and can be found upregu-
lated in cancer (Casero and Marton, 2007). The metabolism of
polyamines starts from the decarboxylation of ornithine to pu-
trescine, a rate-limiting step catalyzed by ornithine decarboxy-
lase (ODC), the crucial gatekeeper of polyamine metabolism.
Putrescine is converted to spermine, which is in turn transformed
to spermidine (Tavladoraki et al., 2012).
Given their critical role, the intracellular concentration of
polyamines is kept under tight control by various mechanismslopmental Cell 35, 21–35, October 12, 2015 ª2015 Elsevier Inc. 21
affecting their biosynthesis, catabolism, and transport. The con-
version of ornithine to putrescine represents the most critical
regulated step. Indeed, the intracellular levels of ODC are
promptly adjusted to the cellular needs thanks to different mech-
anisms affecting its protein stability, transcription, and transla-
tion (Shantz and Levin, 2007). Overexpression of ODC and
polyamines are found in a number of malignancies and targeting
ODCwith the irreversible inhibitor difluoromethylornitine (DFMO)
is highly efficient in limiting some malignancies, such as lym-
phomas or neuroblastomas (Nilsson et al., 2005; Rounbehler
et al., 2009).
With the aim of identifying downstream inhibitors of Hh
signaling, we have found a mechanism whereby this pathway
controls polyamine metabolism via an AMP kinase (AMPK)-
dependent control of ODC biosynthesis. This mechanism in-
volves the small zinc finger protein CNBP, which promotes
translation of ODC, in association with the cytoplasmic Hedge-
hog (Hh) transducer Sufu. Finally, we show that CNBP and poly-
amine metabolism are necessary for Hh-dependent growth and
that their inhibition can be exploited for treatment of Hh-depen-
dent MB.
RESULTS
Hh-Dependent Proliferation Is Accompanied by an
Increase of Polyamine Biosynthesis and Is Inhibited
by DFMO
To determine whether Hh activation is associated with changes
in polyamine metabolism, we studied cerebellar granule cell pro-
genitors (GCPs), the cells of origin of Hh-dependentMB (Schu¨ller
et al., 2008). Exposure of GCPs to Shh induced a significant
elevation of the three polyamines, putrescine, spermine, and
spermidine, accompanied to a robust increase of cell prolifera-
tion (Figures 1A and 1B). The ODC inhibitor DFMO counteracted
the increase of proliferation (Figure 1B), thus indicating that
polyamine biosynthesis is required for GCPs proliferation. The
anti-proliferative effect of DFMO could not be attributed to an in-
hibition of canonical Hh-dependent transcription, as the mRNA
levels of the Hh targets Gli1 and Ptch were not changed by this
drug (Figure S1A). To investigate if the Hh-induced elevation of
polyamines was caused by upregulation of ODC, we measured
its mRNAs and protein levels. Interestingly, ODC protein content
was increased after treatment of GCPs with Shh, while ODC
mRNA levels were unchanged, indicating an Hh mediated
post-transcriptional regulation of ODC (Figures 1C and S1B).
The increase of ODC protein and polyamine levels was also
observed in mouse embryonic fibroblasts (MEFs) treated with
the Smo agonist SAG (Figures S1C and S1D). To understand
at what level of the Hh transduction pathway this regulation oc-
curs, we used MEF cells deleted of genes encoding two key Hh
inhibitors: Ptch and the cytoplasmic transducer Sufu (Sva¨rd
et al., 2006). Surprisingly, while DFMO significantly inhibited
Ptch/ MEF proliferation (Figure 1D, left), this drug failed to
inhibit Sufu/ cell growth (Figure 1D, right). Consistently, addi-
tion of putrescine, the downstream metabolite derived from the
ODC-dependent decarboxylation of ornithine, increased the
proliferation rate only in Sufu/ cells, further indicating that
the absence of Sufu impairs this metabolic step. Supporting
this finding, we observed that the protein levels of ODC (Figures22 Developmental Cell 35, 21–35, October 12, 2015 ª2015 Elsevier I1E, bottom and S1E) and of the three polyamines (Figure 1F)
were significantly higher in Ptch/ than in Sufu/ cells, while
ODC mRNA levels were not different in the two cell lines (Fig-
ure 1E, top). Gli1 protein levels were also comparable in both
cell lines, indicating a similar degree of activation of the Hh-
dependent transcriptional output (Figure 1E). Knock down of
ODC in Ptch/ MEF cells caused a significant decrease of cell
proliferation and polyamine content (Figure S1F), confirming
the importance of this enzyme for cell proliferation in this context.
Therefore, these data indicate that ODC protein is upregulated
via a Sufu-mediated mechanism acting at post-transcriptional
level. Since Sufu did not affect ODC stability (Figure S1G), this
suggests that Sufu regulates ODC biosynthesis, likely affecting
the function of some unknown modulator.
Sufu Binds and Stabilizes CNBP to Regulate ODC
Translation
To shed light on this, we expressed FLAG-tagged Sufu in
HEK293 cells and performed mass spectrometry analysis on
FLAG immunoaffinity purified Sufu-bound proteins. Among the
hits with the highest coverage (Table S1), we found CCHC type
Nucleic acid Binding Protein (CNBP), a zinc finger protein that
binds single stranded RNA and DNA and functions as a nucleic
acid chaperone (Calcaterra et al., 2010). Notably, CNBP was
shown to regulate ODC translation through an internal ribosome
entry site (IRES)-mediated mechanism (Sammons et al., 2010).
We generated and validated a CNBP antibody (Figure S2A)
and confirmed the ability of CNBP to bind Sufu at an endogenous
level and in vitro (Figures 2A and S2B). We also ruled out the
involvement of CNBP in the Sufu-mediated regulation of Gli tran-
scriptional activity, stability, and processing and any competition
with the Gli/Sufu complex (Figures S2C–S2F).
Knock down of CNBP with different shRNAs caused a reduc-
tion of ODC protein levels (Figure 2B, middle). To confirm that
this reduction was related to the ability of CNBP to regulate
ODC IRES-dependent translation, we used the bicistronic
ODC-Luc vector (Sammons et al., 2010) (Figure 2B, bottom).
This construct contains: (1) the renilla CDS, (2) the luciferase
CDS, and (3) the intercistronic ODC 50UTR. This cassette is ex-
pressed as a single transcript, under the control of the CMV pro-
moter. Translation of the renilla gene (the most 50 of the two open
reading frames, ORFs) is cap-dependent and terminates with the
TAA stop codon. Translation of the luciferase gene occurs
through the ODC internal initiation site (IRES), located in the in-
tercistronic region. Therefore, the luciferase values represent
theODC IRES activity of the intercistronic region and are normal-
ized for the constitutive renilla activity (Sammons et al., 2010).
Knock down of CNBP reduced the luciferase, but not the renilla
activity, confirming the ability of this protein to regulate ODC
IRES-dependent translation (Figure 2B, top).
Northern blot analysis of RNA extracted from control or CNBP-
deficient cells transfected with ODC-Luc did not show the pres-
ence of accessory bands, demonstrating that the effect of CNBP
was not related to RNA splicing processes (Figure S2G) of the bi-
cistronic transcript.
To rule out potential plasmid artifacts and to verify that this
effect was a genuine IRES-dependent process, we transfected
NIH 3T3 cells with in vitro transcribed, monocistronic IRESODC-
Luciferase mRNA, conjugated to the non-physiological capnc.
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Figure 1. Hh Signaling Promotes Polyamine Biosynthesis
(A) Polyamine levels in P7 GCPs treated with Shh or BSA as control for 48 hr (*p < 0.01 Shh versus BSA). The polyamine content was measured by GC-MS and
normalized to the protein concentration in the extracts (nmol/mg protein). The results are expressed as fold change, relative to untreated cells for each polyamine
and represent the average ± SD of three independent experiments, each performed in triplicate (putrescine, Put; spermine, Spm; and spermidine, Spd).
(B) BrdU incorporation assay on GCPs treated with DFMO (5 mM) for 72 hr and with Shh or BSA as control for the last 48 hr (*p < 0.01 Shh versus BSA and
**p < 0.05 Shh DFMO versus Shh NT). The results are shown as the average ± SD of three independent experiments, each performed in triplicate.
(C) ODC mRNA levels normalized by GAPDH levels (top) and ODC protein levels (bottom) in P7 GCPs treated with Shh or BSA as control for 24 hr; actin, loading
control. The results are shown as the average ± SD of three independent experiments, each performed in triplicate.
(D) Cell proliferation assay in Ptch/ (left) and Sufu/ (right) MEF cells treated with DFMO (5 mM), putrescine (Put, 10 mM) alone, or in combination for 48 hr
(*p < 0.01 DFMO versus NT 48 hr; **p < 0.05 DFMO+Put versusDFMO48 hr; and ***p < 0.05 Put versusNT 48 hr). The results are shown as the average ±SDof four
independent experiments, each performed in triplicate.
(E) ODC mRNA normalized by GAPDH mRNA levels (top) and ODC protein level (bottom) from Ptch/ and Sufu/ cells; actin, loading control. The results are
shown as the average ± SD of three independent experiments, each performed in triplicate.
(F) Polyamine levels in Ptch/ and Sufu/ MEF cells (*p < 0.05 Sufu/ versus Ptch/). The results are expressed as fold change of polyamine content in
Sufu/ compared to Ptch/ cells and represent the average ± SD of three independent experiments, each performed in triplicate. See also Figure S1.analog ApppG, and containing a stable stem loop structure at
the 50 end to inhibit scanning (Gilbert et al., 2007) (Figure 2C,
bottom). Compared to 7mGpppG-capped mRNA, the in vivoDevetranslational efficiency of the ApppG-capped Hairpin-containing
mRNA lacking the IRES sequence (IRES), was strongly
reduced by 30-fold (Figure 2C, left). Insertion of the ODClopmental Cell 35, 21–35, October 12, 2015 ª2015 Elsevier Inc. 23
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Figure 2. Identification of the CNBP-Sufu-ODC Axis
(A) CoIP of FLAG-tagged (top) or endogenous (bottom) Sufu with endogenous CNBP in MEF cells; Input 2.5%, In.
(B) The top image shows IRES translation assay on MEF cells transfected with ODC-Luc plasmid and either two distinct CNBP (shCNBP1 and shCNBP2) or
scrambled shRNA vectors (shCtr). The results are expressed as fold change compared to the shCtr transfected cells. The luciferase values indicate the IRES-
mediated translational activity of the ODC 50UTR sequence and are normalized by the Renilla values, representing cap-dependent translation of the same
transcript. The results are shown as the average ± SD of five independent experiments, each performed in triplicate (*p < 0.01). The middle image shows protein
levels of ODC, CNBP, and actin (loading control). The bottom image shows a schematic representation of the ODC-Luc vector. See Results for details.
(legend continued on next page)
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50 UTR IRES sequence (+IRES) significantly increased the trans-
lational efficiency of ApppG-Hairpin mRNA (Figure 2C, right).
This confirmed the presence of genuine IRES activity in the
ODC 50UTR (Pyronnet et al., 2000). CNBP depletion significantly
reduced this IRES-dependent activity (Figure 2D, left), whereas
exogenous CNBP induced translation of ApppG +IRES mRNA,
but did not change the translational activity of control IRES
(Figure 2D, right). Thus, CNBP is a bona fide regulator of ODC
IRES-dependent translation.
Ablation of CNBP decreased polyamines levels (Figure 2E, left)
and the proliferation rate of MEF Ptch/ cells, and this effect
was rescued by addition of putrescine (Figure 2E, right), support-
ing that loss of CNBP impairs the same metabolic step of Sufu.
To determine whether Sufu and CNBP are both associated
with translational complexes, we performed polysomal fraction-
ation. As shown in Figures 2F and S2H, CNBP and Sufu copuri-
fied in the polyribosomes fractions and EDTA treatment, which
displaces the binding between the ribosomal subunits, disrupted
this association, demonstrating that both proteins are associ-
ated with actively translating complexes. CNBP and Sufu were
also bound to ODC mRNA, as revealed by RNA-IP (Figure 2G),
further indicating their involvement in ODC translation. Consis-
tently, the absence of Sufu caused a reduction of ODC-Luc ac-
tivity (Figure 2H), indicating that Sufu is involved in the regulation
of ODC translation. Interestingly, we observed a reduction of
CNBP protein, but not mRNA levels, in Sufu-deficient cells (Fig-
ure 2I, bottom), suggesting that Sufu regulates CNBP at post-
transcriptional level.
Based on previous data illustrating the ability of Sufu to bind
and stabilize Gli proteins (Chen et al., 2009; Humke et al.,
2010; Wang et al., 2010), we hypothesized that Sufu could play
a similar role in this context, by preventing CNBP degradation.
Toward this end, we incubated wild-type (WT) and Sufu/ cells
with the protein synthesis inhibitor cycloheximide (CHX) for
different time points and observed that CNBP half-life was signif-
icantly shorter in Sufu-deficient cells (Figure 3A). The specific
involvement of Sufu was demonstrated by its retroviral-mediated(C) In vivo translation of monocistronic 7mGpppG-capped (7mGpppG-Luc) and
-IRES) or with human ODC IRES (ApppG-Hairpin-ODC-Luc, +IRES). After in vit
transfected in NIH 3T3. The luciferase values were normalized by qPCR analysis o
four independent experiments, each performed in triplicate. The bottom image s
(D) In vivo translation of ApppG-capped polyA+ monocistronic Hairpin-Empty-Luc
siCNBP, siCtr (left), and with either CNBP or empty expression plasmids (right)
as assessed by qPCR (*p < 0.05 siCtr, +IRES versus siCtr, IRES; **p < 0.05
Empty, +IRES). The results are shown as the average ± SD of three independen
(E) Polyamine levels (left) in MEF Ptch/ cells transfected with either CNBP (shCN
on the right shows a cell proliferation assay from cells transfected as above (*p <
48 hr). The results are shown as the average ± SD of three independent experim
(F) Analysis of CNBP and Sufu association with polysomes in subconfluent WTME
left). To assess the specificity of protein co-fractionation, an aliquot of the cell l
gradient containing 10 mM EDTA (+EDTA, right). The presence of CNBP and S
ribosomal proteins and purity of the fractions along the gradient was controlled
(G) RNA-IP of ODC mRNA. The NIH 3T3 cells were crosslinked and lysed. The ly
eluted mRNAs were reverse transcribed and quantified by qPCR with primers enc
relative to IgG control (*p < 0.05). The results are shown as the average ± SD of
(H) The top image shows IRES-translation assay on MEF cells transfected with
(*p < 0.01). The results are shown as the average ± SD of three independent expe
protein levels.
(I) CNBP and Sufu protein (top) and mRNA levels (bottom) normalized by HSP70
shown as the average ± SD of three independent experiments, each performed
Devereconstitution in Sufu/ cells, which restored CNBP levels (Fig-
ure 3B). Incubation of Sufu/ cells with the proteasome inhibitor
MG132 rescued the expression of CNBP and of Gli3, used as
control (Chen et al., 2009), indicating the involvement of protea-
somal degradation in this process (Figure 3C). In agreement with
this observation, we found that both ectopic and endogenous
CNBP were efficiently polyubiquitinated, a process that was
increased by Sufu knockdown and decreased by its overexpres-
sion (Figures 3D, 3E, S3A, and S3B). Thus, Sufu binds CNBP
and prevents its ubiquitination and proteosomal degradation,
thereby increasing its stability.
Hh Activation Increases ODC Biosynthesis via
AMPK/CNBP
Since we observed increased expression of ODC protein and
polyamine biosynthesis in Hh-activated cells (Figures 1A, 1C,
and S1B–S1D), we next wondered whether and how activation
of Hh pathway perturbs this Sufu/CNBP-mediated mechanism.
In co-immunoprecipitation studies with equal amounts of
CNBP, we observed that upon exposure of cells to SAG, the
binding to endogenous Sufu was promptly increased (Figures
4A and S4A), leading to accumulation of CNBP protein (Figures
4B and S4B). Similarly, CNBP levels were higher in Ptch/ cells,
compared to control cells and in GCPs treated with Shh peptide
(Figures 4C and S4C).
To determine whether this upregulation is associated with an
increased translational activity of CNBP, we performed polyso-
mal fractionation analysis in control and Hh-activated cells.
Following SAG activation, CNBP was loaded on polysomal
fractions and EDTA treatment disrupted this association (Figures
4D, S4D, and S4E). Consistently, treatment with SAG increased
the recruitment of CNBP to ODC 50UTR in RNA-IP experiments
(Figure 4E). Paralleling CNBP, ODC protein levels were upregu-
lated in Ptch/ MEF cells, compared to WT MEF cells, and
knock down of CNBP abolished this effect (Figure 4F). The in-
crease of ODC protein was not dependent on differences in
mRNA synthesis and/or stabilization, since ODC mRNA levelsApppG-capped polyA+ Luciferase mRNA either without (ApppG-Hairpin-Luc,
ro translation and modifications (see Experimental Procedures), mRNA were
f luciferase mRNA levels (*p < 0.05). The results represent the average ± SD of
hows a schematic representation of the monocistronic vector.
(IRES) or Hairpin-ODC-Luc (+IRES) vectors in NIH 3T3 cells transfected with
. The values indicate luciferase activity normalized to luciferase mRNA levels
siCNBP, +IRES versus siCtr, +IRES; and ***p < 0.01 CNBP, +IRES versus
t experiments, each performed in triplicate.
BP) or scrambled (shCtr) shRNAs (*p < 0.05 shCNBP versus shCtr). The image
0.05 shCNBP versus shCtr 48 hr and **p < 0.01 shCNBP+Put versus shCNBP
ents, each performed in triplicate (putrescine, Put).
F cells. The lysates were separated on a 15%–50% sucrose gradient (EDTA,
ysate was treated with 35 mM EDTA (pH 7.4) and separated on a 15%–50%
ufu protein in each fraction was analyzed by western blotting. Distribution of
with rpS19 and vinculin staining, respectively.
sates were immunoprecipitated with CNBP, Sufu, or control IgG antisera. The
ompassing actin and ODC 50UTR. The results are indicated as fold difference,
four independent experiments, each performed in triplicate.
ODC-Luc and either Sufu (siSufu1 and siSufu2) or scrambled siRNAs (siCtr)
riments, each performed in triplicate. The bottom image shows Sufu and actin
and GAPDH levels, respectively, in WT and Sufu/ MEF cells. The results are
in triplicate. See also Figure S2.
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Figure 3. Sufu Prevents CNBP Degradation
(A) Left, CNBP and actin levels in WT or Sufu/
MEF cells incubated with CHX (100 mg/mL) for the
indicated times. The image on the right shows a
densitometric analysis. The value 1 was assigned
to time 0. The results represent the average ± SD of
three independent experiments (*p < 0.05).
(B) CNBP protein levels in Sufu/ MEF cells
transduced with empty (Ctr) or Sufu (rSufu) retro-
viruses (actin, loading control).
(C) Effect of 6 hr treatment with 50 mM MG132 on
CNBP levels in Sufu/ MEF cells. The full length
Gli3 (Gli3FL) levels are shown as control of MG132
efficacy.
(D) Ubiquitination assay in MEF cells transfected
with FLAG-tagged CNBP, HA-Ub, and siSufu (left)
orMyc-Sufu (right). The filters were probedwith HA
antibody to detect ubiquitination and with FLAG,
MYC, and actin antibodies for the other proteins.
(E) Endogenous ubiquitination assay in MEF cells
transfected with HA-tagged Ub and Myc-tagged
Sufu vectors. The filters were probed as indicated.
See also Figure S3.were unchanged (Figure S4F), neither could be attributed to var-
iations of protein stability, as there were no differences in ODC
degradation rate between WT and Ptch/ cells (Figure S4G).
The addition of the protein synthesis inhibitor CHX prevented
the Hh-induced upregulation of ODC (Figure S4H), thus indi-
cating that the increase was dependent on translation. To
directly demonstrate an increase in ODC protein synthesis, we
performed in vivo metabolic [35S]-methionine labeling followed
by ODC immunoprecipitation (IP). Compared to WT cells,
Ptch/ cells showed a significant increase of metabolically
labeled, newly synthesized ODC protein in the presence of the
proteasome inhibitor MG132 (Figures 4G and S4I). Consistently,
treatment of cells with SAG strongly increased the ODC-Luc
IRES-dependent activity, and this effect was disrupted by
CNBP knockdown (Figure 4H). Therefore, Hh induces ODC
translation through CNBP.
We next sought to understand the signaling pathway connect-
ing Smo to CNBP. Toward this end, we analyzed the CNBP
sequence to identify putative residues that could be subjected
to post-translational modifications. We noticed a potential
AMPK-consensus site (LARECTIEAT), evolutionary conserved
(Figure 5A), located in the C-terminal region that diverged from
the optimal AMPK site for having the T in position +4 instead of
a hydrophobic residue. A similar variation was previously identi-
fied in one of the AMPK sites of FOXO3 (Greer et al., 2007).26 Developmental Cell 35, 21–35, October 12, 2015 ª2015 Elsevier Inc.Since it was recently shown that Hh
activation directly activates AMPK via
non-canonical Ca2+-dependent activa-
tion of CAMKK2 (Teperino et al., 2012),
we tested if AMPK is involved in the Hh-
regulated CNBP activation.
SAG-dependent increase of CNBP,
ODC protein levels, and the activity of
ODC-Luc reporter were disrupted in
AMPK/ compared to WT cells (Figures
5B and 5C). Similarly, the AMPK inhibitorCompound C (CC) prevented the increase of ODC and poly-
amines in SAG-treated MEF cells, in Ptch/ MEF cells, and
Shh-treated GCPs (Figures S5A, S5B, and 5D). Elevation of
CNBP and ODC proteins, polyamines, and ODC-Luc activity
could also be observed upon exposure of cells to the direct
AMPK activator A769662 (Figures 5E and S5D) and to KAAD cy-
clopamine (Figures 5F, S5E, and S5F), which binds Smo and acts
as an inhibitor of the canonical pathway, but as a partial agonist
of the non-canonical branch (Teperino et al., 2012). To determine
if cyclopamine activates the non-canonical branch also in tumor
cells driven by constitutive Hh activation, we tested its effect in
primary MB cells generated in conditional Math1-Cre/PtcC/C
mice (Yang et al., 2008). We will refer to these cells as ‘‘primary
MB cells’’ within text and figures. Exposure of these cells to
cyclopamine did not induce AMPK activation and polyamine
production, while it robustly inhibited the expression of the Hh
target gene Gli1 (Figure S5G).
Consistent with previous observations (Teperino et al., 2012),
activation of this non-canonical mechanism is dependent on the
integrity of the primary cilium, since SAG failed to induce CNBP,
AMPK phosphorylation, and putrescine content in cilia-deficient
Itf88/ MEF cells (Figure S5H).
Thus, activation of the non-canonical Hh-AMPK pathway pro-
motes upregulation of ODC and polyamines in normal cells, but
not in tumors sustained by loss of Ptch1.
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Figure 4. CNBP Controls ODC Translation in Response to Hh
(A) Endogenous association of Sufu to CNBP in MEF cells treated with SAG or DMSO for 4 hr. The cells were lysed and immunoprecipitated with saturating
amounts of CNBP or control (IgG) antisera, as indicated.
(B and C) CNBP levels in MEF cells treated with SAG or DMSO for 4 hr (B) and in WT and Ptch/ MEF cells (C); actin, loading control.
(D) Polysomal recruitment of CNBP in SAG-treated NIH 3T3 cells. The cells were grown in low serum (0.5% BS) medium overnight to allow full Hh response and
then treated with either DMSO or SAG for 4 hr. The cells were lysed and loaded onto a 15%–50% sucrose gradient in the presence or absence of EDTA, as
described in Figure 2D. The CNBP protein levels in each fraction were analyzed by western blotting.
(E) RNA-IP of ODCmRNA. The NIH 3T3 cells, treated with SAG or DMSO for 4 hr, were crosslinked and lysed. The lysates were immunoprecipitated with CNBP or
control IgG antisera. The eluted ODC mRNAs were analyzed as in Figure 2E. The results are indicated as fold difference, relative to IgG control (*p < 0.05 CNBP
DMSO versus IgG and **p < 0.05 SAGCNBP versus DMSOCNBP). The results are shown as the average ± SD of four independent experiments, each performed
in triplicate.
(F) ODC and CNBP protein expression in WT and Ptch/ MEF cells, transfected for 72 hr with siCtr or siCNBP (actin, loading control).
(G) WT and Ptch/ MEF cells pre-treated with 50 mMMG132 for 2 hr and cultured for 30 min with [35S]-methionine to label newly synthetized proteins. The cell
lysates were immunoprecipitated with ODC antisera and the immunocomplexes were revealed by autoradiography (top). A fraction of the IP was analyzed by
western blot and showed equivalent amounts of ODC levels. The controls include analysis of whole cell extracts (WCE), where comparable amounts of [35S]-
methionine were incorporated into WT and Ptch/ MEF cells (bottom).
(H) Activity of the ODC-Luc vector in NIH 3T3 cells treated with SAG or DMSO for 6 hr after 72 hr transfections with siCNBP or siCtr (*p < 0.01 siCtr SAG versus
siCtr DMSO and **p < 0.05 shCNBP SAG versus shCtr SAG). The results represent the average ± SD of three independent experiments, each performed in
triplicate. See also Figure S4.To determine if CNBP is phosphorylated by AMPK at the puta-
tive threonine 173, we performed in vitro kinase assay with re-
combinant CNBP or its T173A mutant. WT CNBP efficiently
incorporated 32P in the presence of AMPK, whereas the T173A
mutant did not (Figure 5G), thus demonstrating that AMPK phos-
phorylates CNBP only at this residue. We then immunoprecipi-
tated ectopically expressed CNBP from WT and AMPK/ cells
and performed western blotting with an antibody recognizingDeveAMPK-phosphorylated substrates. CNBP was phosphorylated
in WT, but not AMPK/ cells (Figure 5H). Activation of Hh with
SAG increased the AMPK-mediated phosphorylation of both
endogenous and ectopic CNBP (Figures 5I and 5J), and this
modification was completely abrogated by mutation of the
T173 residue to alanine (Figure 5J). To study the activity of the
T173A mutant and to rule out the possibility of overexpression
artifacts, we knocked down endogenous CNBP with shRNAlopmental Cell 35, 21–35, October 12, 2015 ª2015 Elsevier Inc. 27
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Figure 5. AMPK Promotes ODC Translation in Response to Hh Agonists by Phosphorylating CNBP at the Conserved Threonine 173
(A) Protein alignment of the amino acid sequence of CNBP surrounding T173. The optimal AMPK consensus motif is shown.
(B) ODC, CNBP, total, and phosphorylated AMPK protein levels in WT and AMPK/ MEF cells treated with DMSO or SAG for 6 hr (actin, loading control).
(C) Activity of the bicistronic ODC-Luc vector transfected for 48 hr inWT andAMPK/MEF cells and treatedwith DMSOor SAG for 6 hr (*p < 0.01WTSAG versus
WT DMSO and **p < 0.01 AMPK/ SAG versus WT SAG). The results are shown as the average ± SD of three independent experiments, each performed in
triplicate.
(D–F) CNBP, ODC, total, and phosphorylated AMPK protein levels in GCPs stimulated with Shh for 6 hr in the absence or presence of CC (20 mM) (D), or with the
AMPK agonist A769662 (25 mM) (E), or treated with KAAD-cyclopamine (KAAD, 0.1 mM) for the indicated times (F) (tubulin, loading control).
(G) In vitro AMPK-phosphorylation assay of recombinant GST-CNBPWT or T173A mutant. The incorporation of 32P was determined by autoradiography and the
protein levels were detected by Coomassie blue staining.
(H) WT and AMPK/MEF cells were transfected with a plasmid encoding FLAG-CNBP. The cell extracts were immunoprecipitated with anti-FLAG antibody and
phosphorylation was revealed with an anti-phospho AMPK substrate (pAMPKsub) antibody. Equivalent amounts of FLAG-CNBP are shown after FLAG
immunoblot.
(legend continued on next page)
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targeting the 30UTR region and reintroduced WT and T173A
CNBP (Figure S5I). Reconstitution of CNBP-deficient cells with
CNBP WT rescued ODC-Luc activity and putrescine levels,
whereas the T173A mutant had a significantly reduced activity
(Figures 5K and S5I).
The CNBP T173A mutant was no longer upregulated by SAG
(Figure S5J) and showed a significantly reduced half-life
compared to the WT protein (Figure S5K).
Since the stability of CNBP depends on its association with
Sufu, we tested the binding of Sufu to CNBP WT, T173A, and
the phosphomimetic T173D mutant. Compared to WT CNBP,
the T173A mutant bound Sufu with reduced affinity, while the
T173D showed an increased affinity (Figures 5L and S5L), indi-
cating that phosphorylation of T173 favors the formation of the
complex.
In keeping with this finding, the phosphomimetic T173D
mutant promoted significantly higher ODC-Luc activity and poly-
amines production (Figure S5M).
Collectively, these data indicate that T173 phosphorylation
represents the critical regulated checkpoint of this Hh/AMPK-
mediated regulation of CNBP.
ODC and CNBP Are Elevated in MB, and their Targeting
Prevents MB Growth
To explore the pathophysiological relevance of this mechanism,
we analyzed CNBP and ODC levels in Hh-dependent MB devel-
oped in conditional Math1-Cre/PtcC/C mice, where Hh signaling
is constitutively hyperactive (Figure S6A). Compared to a normal
adult cerebellum, CNBP, ODC, Sufu, and phosphorylated AMPK
were elevated in MB samples (Figures 6A and S6B), and this was
accompanied by a strong upregulation of the three polyamines
(Figure 6B).
We next analyzed CNBP and ODC expression in a cohort of
42 human MBs, divided according to the molecular subgroup
(five wingless, WNT; seventeen SHH; ten group 3; and ten group
4) as previously described (Mastronuzzi et al., 2014; Miele et al.,
2015).
CNBP and ODC staining were strongly increased in the SHH
molecular subgroup compared to a normal adult cerebellum,
which showed a negative staining for ODC and a weak positivity
for CNBP. A positive staining of CNBP and ODC was also
observed in the group 3, while the WNT and group 4 molecular
subgroups displayed a weaker staining (Figure 6C). Negative
controls were also performed (Figure S6C).
We next analyzed the cohort of seventeen human SHH MBs
belonging to the three histological subgroups: desmoplastic,
classic, and large cell anaplastic (LCA) (Kool et al., 2012; North-
cott et al., 2012b). The staining for both CNBP and ODC was(I) Endogenous CNBP phosphorylation in MEFWT cells treated with DMSO or SA
or control (IgG) antisera, as indicated. The filters were stained with pAMPKsub a
(J) MEFWT cells expressing HA-taggedWT or T173Amutant CNBPwere treatedw
HA antibody and equal levels of CNBP were loaded. The phosphorylation was re
with HA antibody to confirm comparable WT and mutant protein levels.
(K) Activity of the bicistronic ODC-Luc vector in CNBP-depleted MEF WT, recons
siRNA (siCtr) or a siRNA targeting CNBP 30UTR region for 72 hr and with the indic
CNBPi 30UTR +WT versus CNBPi 30UTR; and ***p < 0.05 CNBPi 30UTR + T173A v
independent experiments, each performed in triplicate.
(L) CoIP of endogenous Sufu with WT, T173A, and T173D HA-tagged CNBP in W
and the filters were stained with Sufu, HA, and pAMPKsub antibodies. The Input
Devestrongly positive in all the MB analyzed independently of their
histological classification (Figure 6D).
The strong increase of CNBP, ODC, and polyamine levels in
Hh-dependent tumors prompted us to evaluate the conse-
quence of turning off this mechanism in tumor cells.
We first tested different shRNA expressing lentiviruses target-
ing CNBP for their efficacy in knocking down CNBP and conse-
quent ODC downregulation in primary SHH MB (Figure 7A). We
selected the shRNA #58 and used it in all the subsequent
experiments.
Ablation of CNBP caused a significant reduction of polyamine
content (Figure 7B) and cell proliferation in primary SHHMB cells
and in Shh-treated GCPs, as assessed by BrdU incorporation
assays (Figures 7B, 7C, and S7A).
Exposure of primary SHH MB cells to DFMO resulted in a
robust inhibition of tumor cell proliferation (Figure 7D), without
affecting Gli1 mRNA levels (Figure S7B). Accordingly, the levels
of the three polyamines putrescine, spermine, and spermidine in
MB cells were downregulated by this drug (Figure 7E).
To determine whether DFMO could inhibit proliferation of
tumors sustained by upregulation of Gli, independently of
upstream activation of Smo, we used the TC-71 tumor cells.
Gli1 drives the proliferation of these cells as a consequence of
downstream events causing its aberrant transcription (Beau-
champ et al., 2009, 2011). Indeed, the direct Gli1 inhibitor ATO
strongly inhibits proliferation of these cells, while they do not
respond to the treatment with cyclopamine (Beauchamp et al.,
2011).
Compared to the Ptch/MEF cells, TC-71 cells showed com-
parable levels of Gli1 (Figure 7F). Treatment of these cells with
DFMO did not affect their proliferation, while ATO had a strong
inhibitory effect (Figure 7G). Knock down of Gli1 caused a signif-
icant decrease of their proliferation, without affecting polyamine
levels (Figure 7H). Thus, Gli1-driven proliferation does not require
changes of polyamine content.
To study the effect of targeting the CNBP/ODC axis in vivo, we
allografted tumor cells explanted from Ptch/ MB and stably
transduced with shCNBP or control lentiviruses into nude
mice. When the tumor reached the volume of 100 mm3, half of
the mice from each group were treated with 0.5% DFMO in the
drinking water until the end of the experiment, monitoring the
growth of the tumor every other day. As shown in Figures 7I,
7J, and 7K, MB growth and polyamine content were strongly
reduced in CNBP-deficient tumors, compared to controls. Inhi-
bition of ODC with DFMO also had a similar inhibitory effect on
tumor growth and polyamine content. Notably, DFMO did not
cause a further decrease of the growth and polyamine levels,
neither a reduction of Gli1 mRNA (Figure S7C), in tumorsG for 2 hr. The cell extracts were immunoprecipitated with anti-CNBP antibody
nd reprobed with CNBP antibodies (Input = 5%).
ith DMSOor SAG for 6 hr. The cell extracts were immunoprecipitatedwith anti-
vealed with anti phospho-AMPK substrate antibody. The filters were reprobed
tituted with WT and T173A HA-CNBP. The cells were transfected with a control
ated plasmids for the last 48 hr (*p < 0.01 CNBPi 30UTR versus siCtr; **p < 0.01
ersus CNBPi 30UTR +WT). The results are shown as the average ± SD of three
T MEF cells. The cell extracts were immunoprecipitated with anti-HA antibody
samples (5%) were probed with Sufu and HA antibodies. See also Figure S5.
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Figure 6. CNBP and ODC Proteins Are
Highly Expressed in Mouse and Human MB
(A) Western blot analysis of WT cerebella and
Ptch/MBsamples. The staining for CNBP,ODC,
pAMPK, AMPK, Sufu, and actin as loading control
are shown.
(B) Polyamine levels in normal cerebellum and
Ptch/ MB tissue samples. The results are the
average ± SD of three different samples for each
condition (*p < 0.05 MB versus Cerebellum).
(C) Representative images of immunohistochem-
istry (IHC) staining for CNBP and ODC in human
adult normal cerebellum and human MB, sub-
divided according to their molecular subgroup
(wingless, WNT; SHH; group 3; and group 4). The
nuclei were counterstained with hematoxylin (403
original magnification at light microscopy, and the
scale bars represent 100 mM).
(D) Immunohistochemistry of human adult normal
cerebellum and human LCA, Classic, and Des-
moplastic MB of the SHH subgroup, stained with
anti-CNBP and anti-ODC antibodies. The nuclei
were counterstained with hematoxylin, and the
scale bars represent 100 mM. See also Figure S6.depleted of CNBP, demonstrating that this drug requires CNBP
to exert its effect.
Taken together, these data show that CNBP and ODC are
elevated in Hh-dependent MB and that genetic or pharmacolog-
ical targeting of the Hh-ODC axis is effective in counteracting the
growth of MB both in vitro and in vivo.
DISCUSSION
In this work, we have demonstrated the ability of Hh signaling to
control a druggable metabolic process, which is required for
normal and MB growth.
The non-canonical Smo/AMPK-dependent signaling route
was originally identified in adipocytes, muscle cells, and fibro-
blasts, where it promotes a rapid metabolic rewiring toward
glycolysis and increase of glucose uptake (Teperino et al.,
2012). Here, we provide evidence that the same transduction
axis is essential to control the proliferation of cerebellar GCPs
and their tumor counterpart by regulating ODC, the key gate-
keeper of polyamines metabolism.
The levels of ODC are controlled by CNBP, a small conserved
protein known to regulate neuronal cell proliferation and fore-
brain development (Chen et al., 2003), in response to unknown
signals. We show here that following Hh activation, CNBP is30 Developmental Cell 35, 21–35, October 12, 2015 ª2015 Elsevier Inc.phosphorylated at T173 by AMPK and
promotes translation of ODC, thereby
controlling cell proliferation. Thus, in
contrast to the classical mode of action
as a tumor suppressing kinase, here
AMPK is engaged in a process that sup-
ports, rather than counteracts, tumor cell
growth. These observations are in line
with the emerging view that AMPK may
act as tumor suppressor or a contextual
oncogene, depending on degree or dura-tion of its activation (Liang and Mills, 2013). It is likely that
Hh signaling activates AMPK to a level where it prevails its
tumor promoting effect. Interestingly, we also show a role for
AMPK in promoting, rather than inhibiting, a translational
process. Indeed, our findings illustrate that, by activating
CNBP, AMPK promotes IRES-dependent translation, an emer-
gency mechanism utilized by cells to cope with different adverse
conditions, including metabolic, hypoxic, or oncogenic stress
(Spriggs et al., 2008).
In a previous work, it was proposed that in cardiac myoblasts,
AMPK limits ODC activity, particularly when cells are exposed to
isoproterenol, which was found to phosphorylate AMPK and to
increase polyamine content (Passariello et al., 2012). This sug-
gests a context-dependent role of this kinase in regulating poly-
aminemetabolism, possibly related to its involvement in different
intracellular networks.
All these aspects add a further level of complexity to the role of
AMPK in cancer and underscore the importance to carefully
evaluate the use of AMPK agonists as anti-cancer drugs, taking
into account the possibility of the dual effect on tumor growth
and stress adaptation.
A similar bifunctional mode of action is observed here with
Sufu, which supports ODC translation and polyamine meta-
bolism by increasing the stability of CNBP.
This observation is seemingly paradoxical, since Sufu is
generally described as a tumor suppressor, and its monoallelic
deletion appears to be sufficient to confer a Hh gain-of-function
phenotype in mice (Cooper et al., 2005; Sva¨rd et al., 2006). How-
ever, MB does not develop in Sufu+/ mice, unless they carry a
p53/ background (Lee et al., 2007) and conditional cerebellar
Sufu/ mice do not display signs of early MB or pre-tumoral
lesions, such as thickening of the external granule layer (Kim
et al., 2011; Yang et al., 2008), typically observed in other Hh
gain of function models, such as the cerebellar ptch deletion or
smo activating mutations (Wu et al., 2011). Thus, it is possible
that the lack of MB development in Sufu deficient animals may
reflect the ability of this protein to mediate both tumor suppress-
ing and promoting functions of Hh signaling, like polyamine
biosynthesis.
Mono and biallelic mutations of Sufu have been also found in
human MB (Brugie`res et al., 2012; Pugh et al., 2012; Robinson
et al., 2012) and are believed to cause activation of the canonical
pathway.Whether thesemutations also affect the AMPK-depen-
dent route remains to be determined.
In addition to SHH subgroup, CNBP and ODC protein levels
are elevated in group 3 MBs. While the mechanism underlying
the increase of CNBP has to be established, it is possible that
the elevation of ODC could be attributed, at least in part, to
overexpression of cMyc, a typical alteration found in this
molecular subgroup (DeSouza et al., 2014). Indeed, ODC is a
transcriptional target of cMyc and is typically overexpressed in
cMyc-driven malignacies (Bello-Fernandez et al., 1993; Nilsson
et al., 2005).
A key finding of this work is that targeting of this Hh/CNBP/
ODC metabolic axis efficiently prevents the growth of MB cells
in vitro and in vivo by reducing intracellular polyamine content.
Increased polyamine levels had been observed in MB in an old
study (Scalabrino et al., 1982), but their role and the underlying
mechanisms were not known, as well as the existence of
different molecular MB subgroups. Here, we demonstrate that
a non-canonical, Smo-dependent, and Gli-independent mecha-
nism is responsible for the elevations of the polyamine content
observed in SHH MB.
This evidence appears to be relevant since a growing body of
evidence is documenting the occurrence of resistance to Smo
antagonists in the treatment of MB and other Hh driven tumors.
Explanations to this phenomenon have been provided with the
occurrence of novel Smomutations and/or with the identification
of oncogenic signaling pathways involving ERK, AKT, and
mTOR/S6K1, which promote Smo-independent Gli activation
or non-canonical Gli-independent cascades (Di Magno et al.,
2015). These observations all indicate that full inhibition of the
Hh pathway requires alternative approaches, inhibiting the
signaling at multiple levels rather than targeting the receptor
apparatus alone. Interestingly, the canonical Smo antagonists
cyclopamine and GDC-0449 appear to function as selective par-
tial agonists of this non-canonical Hh/AMPK branch in metabolic
cells (Teperino et al., 2012) and in GCPs. Cyclopamine inhibits
canonical Hh signaling and counteracts cell growth only in
tumors with constitutive activation of the receptor apparatus
(i.e., in Ptch1 loss of function). In these tumors, the activity of
Smo is constitutively increased on both canonical and non-
canonical branches. In addition, cyclopamine efficiently re-Devepresses Gli-dependent transcription, but does not result in any
further activation of the AMPK-polyamine axis in cultured
Ptch/ SHH-MB cells. Therefore, the effect of cyclopamine
differs between normal and tumor cells: in normal cells
cyclopamine acts as a partial agonist of the non-canonical Hh
signaling, but inhibits the canonical route. In contrast, in Hh-
dependent tumors, cyclopamine inhibits the canonical pathway,
but is unable to induce any further activation of the non-canoni-
cal branch.
To address the relevance of the non-canonical AMPK-ODC
pathway in SHH MB, we have targeted both CNBP (shRNA)
and/or ODC (DFMO) and observed a significant inhibition of
the growth of MB cells from conditional Ptch KO mice, where
Smo is constitutively activated. Thus, turning off the non-canon-
ical branch limits MB growth, even if the canonical signaling is
still hyperactive, indicating that both pathways are required for
growth.
Further supporting our findings, a previous report showed that
treatment of Ptch+/ mice with DFMO prevented the formation
of UV-induced basal cell carcinoma, although the underlying
mechanism was not clarified (Tang et al., 2004).
Compared to other chemotherapeutic compounds, DFMO is a
well-tolerated drug with a modest toxicity, consisting in throm-
bocytopaenia, gastrintestinal effects, and reverible hearing
loss. Recent clinical trials have demonstrated its significant
effect as a chemopreventive agent in tumors like neuroblastoma,
skin, and colon cancers (Jeter and Alberts, 2012). Our pre-
clinical data support the use of DFMO also as a pharmacological
agent for MB. Whether this approach, alone, or in combination
with other strategies, will be successful in human MB patients,
thus, represents a relevant open question raised in this work.
EXPERIMENTAL PROCEDURES
Drug Treatments
The ODC inhibitor DFMO (Sigma, 5 mM) and putrescine (Sigma, 10 mM) were
added to the medium for the indicated times.
For SAG treatment, NIH 3T3 cells were incubated in low serum (0.5% BS)
overnight. MEF WT and Itf88/ were incubated in 1% BSA overnight and
then exposed to SAG (200 nM, Enzo Life Sciences) or KAAD (0.1 mM, Calbio-
chem) for the indicated times. MEF Sufu/ and HEK293T cells were treated
with MG132 (50 mM, Sigma) for 6 hr. MEFs cells were treated for the indicated
times with 100 mg/ml protein-synthesis inhibitor CHX (Sigma). GCPs were
treated with recombinant Shh-N-terminal peptide (R&D Systems, 3 mg/ml in
BSA), with KAAD (0.1 mM, Calbiochem), A769662 (25 mM, Santa Cruz Biotech-
nology), for the indicated times.
MEF cells and GCPs were pre-treated with CC (20 mM, Millipore) for 20 min
and then stimulated with SAG or Shh, respectively, for the indicated times. For
polyamine quantitation, MEF Ptch/ and GCPs were treated with 10 mM CC
for 24 hr (Teperino et al., 2012). Primary MB cells were treated with KAAD
(0.5 mM) for the indicated times.
TC-71 cells were treated with 5 mM DFMO (Sigma) or 5 mM arsenic trioxide
(ATO, Sigma) for the indicated times.
Polyamine Analysis
Polyamine content was determined by gas chromatography-mass spectrom-
etry (GC-MS). Cells or tissues were resuspended in 0.2 M HClO4 and pro-
cessed. Values were normalized by the protein concentration.
In Vivo Translation Assay
m7GpppG- and ApppG-capped polyA+ transcripts were obtained by
in vitro transcription of the monocistronic luciferase pSP64-Hairpin-ODC–
Luc (+IRES) or of pSP64-Hairpin-Empty-Luc (IRES) vector, using thelopmental Cell 35, 21–35, October 12, 2015 ª2015 Elsevier Inc. 31
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MEGAscript SP6 kit (Ambion), in reactions containing physiological m7GpppG
or nonphysiological ApppG caps. mRNA transfections were performed with
Lipofectamine 2000 reagent (Invitrogen). After 6 hr of transfection, luciferase
assays were performed and the values were normalized by quantitative
(q)PCR analysis of luciferase mRNA levels.
RNA IP
Cells were treated, formaldehyde crosslinked, lysed, and sonicated. Lysates
were immunuoprecipitated with the specified antibodies and the immunocom-
plexes washed extensively.
Eluted mRNAs were analyzed by real-time qRT-PCR.
MB Allograft Models
A parental murine MBmodel was derived fromMath1-Cre/PtchC/C mice (Yang
et al., 2008). Nude female mice were housed under standard conditions.
Briefly, freshly isolated MB were mechanically dissociated into single-cell sus-
pensions in HBSS (GIBCO) supplemented with Pen/Strep. The 5 3 106 viable
cells were harvested in duplicate and, after 24 hr, infected with control shRNA
or shCNBP58 lentiviral particles. After 96 hr, 2 3 106 viable cells were sus-
pended in equal volumes of PBS andMatrigel (BD PharMingen) and implanted
subcutaneously in both flanks in adult athymic nude mice (Charles River Lab-
oratories). Animals from the two subgroups were randomized and divided in
two further subgroups. Treatment was initiated when tumor volume reached
100 mm3. Mice (control: n = 5 and shCNBP: n = 5) were treated with 0.5%
DFMO in the drinking water or only water (control: n = 5 and shCNBP: n = 5)
and tumors sizes weremeasured every day using a caliper. Volumewas calcu-
lated as V = (L 3W2)/ 2 (Kim et al., 2013). Growth patterns were summarized
graphically by plotting the mean and SD for each treatment group over time.
Study events were recorded and analyzed using GraphPad Prism software
(v6.05).
CNBP knockdown was confirmed by qPCR in all tumor samples at the end
of the experiment.
Statistical Analysis
Statistical analysis was performed using StatView 4.1 software (Abacus Con-
cepts). Results are expressed as mean ± SD from at least three independent
experiments, each performed in triplicate. Statistical differences wereFigure 7. Targeting CNBP/ODC Axis Impairs MB Growth In Vitro and I
(A) Primary MB cells infected with different shCNBP-containing lentiviral particle
shows qPCR analysis of CNBP, ODC, and Gli1 mRNA levels, normalized by GA
experiments, each performed in triplicate.
(B) Polyamine levels in primary MB cells infected with shCNBP clone 58 or control
three independent experiments, each performed in triplicate.
(C) BrdU incorporation assay in primary MB cells infected with shCNBP clone 5
fluorescent stain Hoechst 3342 (blue). The BrdU incorporation was carried out f
expressed as fold change, relative to cells infected with scrambled (*p < 0.05). T
formed in triplicate. The bottom image shows representative pictures. The scale
(D) Cell proliferation assay on primaryMB cells, treatedwith DFMO (5mM, blue) or
the average ± SD of four independent experiments, each performed in triplicate.
(E) Corresponding polyamine levels in the same cells treated as above for 72 hr
(F) CNBP, Sufu, and Gli1 levels in Ptch/ MEF and Ewing Sarcoma TC-71 cell l
(G) Cell proliferation assay in TC-71 cells treatedwith 5mMDFMO, 5 mMATO, or v
activity (ATO), but not by inhibiting ODC (DFMO) (*p < 0.01 ATO versus NT). The
performed in triplicate.
(H) Effect of Gli1 depletion in TC-71 cells. The cells were infected with shGli1-exp
analyzed for polyamine content (middle). The Gli1 RNAi efficiency was assessed
average ± SD of three independent experiments, each performed in triplicate.
(I) Primary MB cells were transduced with shCNBP or control lentiviruses for 96 h
with 0.5%DFMO in the drinking water (DFMO = green, n = 6 and shCNBP DFMO =
n = 6); tumors were measured using a caliper when they reached a volume of at
average ± SD.
(J) Polyamine levels from the above samples. The polyamine content was measur
expressed as fold change relative to untreated mice (H2O) and are shown as the
(K) Representative images of allografted nude mice at day 10 (top), of excised
staining of CNBP in sections from the above samples (bottom, the scale bar rep
Deveanalyzed with the Mann-Whitney U test for non-parametric values and a
p < 0.05 was considered significant.
Full details of the Experimental Procedures and description of standard
techniques are provided in Supplemental Information.
The Institutional Review Board approved the studies involving human sam-
ples and informed consent was obtained from all subjects.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and three tables and can be found with this article online at
http://dx.doi.org/10.1016/j.devcel.2015.09.008.
AUTHOR CONTRIBUTIONS
G.C. conceived and coordinated the project, designed experiments, analyzed
the data, and wrote the paper; D.D.A., L.A., L.D.M., S.C., G.S., E.M., and P.I.
designed and performed experiments and analyzed the data; A.M. and E.A.
performedmeasurements and analysis of the polyamine data; B.C. performed
experiments and analyzed the data of polysome fractionation, in vitro binding
assays, and translational analyses; E.D.S., E.F., L.D.M., L.C., F.G., J.R.Y., I.S.,
and A.G. designed and analyzed the data. All authors critically revised and edi-
ted the manuscript.
ACKNOWLEDGMENTS
We thank Matthew Scott for Ptch/ MEF cells, Robert Wechsler-Reya for
Math1-Cre/ptcC/C mice, Rune Toftgard for Sufu/ cells, and Jeremy Reiter
for MEF Itf88/ cells. We also thank the researchers mentioned in the Supple-
mental Information for providing the specified reagents.
This work was supported by Associazione Italiana per la Ricerca sul Cancro
(AIRC) grant IG 14723, AIRC 5XMILLE, Ministero dell’ Istruzione, dell’ Univer-
sita` e della Ricerca (MIUR), Fondo per gli Investimenti della Ricerca di Base
(FIRB), and Progetti di Rilevante Interesse Nazionale (PRIN) projects, Ministry
of Health, Pasteur Institute-Cenci Bolognetti Foundation, Italian Institute of
Technology (IIT), and NIH P41 RR011823. L.A. and S.C. were supported by fel-
lowships from the Pasteur Institute-Cenci Bolognetti Foundation.n Vivo
s (clones 58, 59, and 66) or a control lentivirus (shCtr) for 96 hr. The top image
PDH (*p < 0.01). The results represent the average ± SD of three independent
(shCtr) lentivirus for 96 hr (*p < 0.05). The results represent the average ± SD of
8 or control lentivirus (shCtr) for 96 hr and stained by BrdU (red) and nuclear
or the last 24 hr. The % of BrdU positive cells was measured and the results
he results are the average ± SD of three independent experiments, each per-
bar represents 100 mM.
vehicle (H2O, black) for the indicated times (*p < 0.01). The results are shown as
(*p < 0.05).
ines; tubulin, loading control.
ehicle (NT) for 72 hr. The results show a reduced cell proliferation by blockingGli
results are shown as the average ± SD of four independent experiments, each
ressing or control lentiviruses (shCtr) for 72 hr. The cells were counted (left) and
by qPCR (right) (*p < 0.01, 0.05, versus shCtr). The results are shown as the
r. The nude mice were allografted with 23 106 viable infected cells and treated
violet, n = 6) or H2O as control (shCtr H20 = blue, n = 6 and shCNBP H20 = red,
least 100 mm3, at the indicated days (*p < 0.01). The results are shown as the
ed by GC-MS and normalized to tissue weight (nmol/mg tissue). The results are
average ± SD (*p < 0.01).
tumors (middle, the scale bar represents 1 cm), and of immunohistochemical
resents 100 mM).
lopmental Cell 35, 21–35, October 12, 2015 ª2015 Elsevier Inc. 33
Received: April 10, 2014
Revised: August 10, 2015
Accepted: September 11, 2015
Published: October 12, 2015
REFERENCES
Beauchamp, E., Bulut, G., Abaan, O., Chen, K., Merchant, A., Matsui, W.,
Endo, Y., Rubin, J.S., Toretsky, J., and Uren, A. (2009). GLI1 is a direct
transcriptional target of EWS-FLI1 oncoprotein. J. Biol. Chem. 284, 9074–
9082.
Beauchamp, E.M., Ringer, L., Bulut, G., Sajwan, K.P., Hall, M.D., Lee,
Y.C., Peaceman, D., Ozdemirli, M., Rodriguez, O., Macdonald, T.J.,
et al. (2011). Arsenic trioxide inhibits human cancer cell growth and tumor
development in mice by blocking Hedgehog/GLI pathway. J. Clin. Invest.
121, 148–160.
Bello-Fernandez, C., Packham, G., and Cleveland, J.L. (1993). The ornithine
decarboxylase gene is a transcriptional target of c-Myc. Proc. Natl. Acad.
Sci. USA 90, 7804–7808.
Brugie`res, L., Remenieras, A., Pierron, G., Varlet, P., Forget, S., Byrde, V.,
Bombled, J., Puget, S., Caron, O., Dufour, C., et al. (2012). High fre-
quency of germline SUFU mutations in children with desmoplastic/nodular
medulloblastoma younger than 3 years of age. J. Clin. Oncol. 30, 2087–
2093.
Calcaterra, N.B., Armas, P., Weiner, A.M., and Borgognone, M. (2010). CNBP:
amultifunctional nucleic acid chaperone involved in cell death and proliferation
control. IUBMB Life 62, 707–714.
Casero, R.A., Jr., and Marton, L.J. (2007). Targeting polyamine metabolism
and function in cancer and other hyperproliferative diseases. Nat. Rev. Drug
Discov. 6, 373–390.
Chen, W., Liang, Y., Deng, W., Shimizu, K., Ashique, A.M., Li, E., and Li, Y.P.
(2003). The zinc-finger protein CNBP is required for forebrain formation in
the mouse. Development 130, 1367–1379.
Chen, M.H., Wilson, C.W., Li, Y.J., Law, K.K., Lu, C.S., Gacayan, R., Zhang, X.,
Hui, C.C., and Chuang, P.T. (2009). Cilium-independent regulation of Gli pro-
tein function by Sufu in Hedgehog signaling is evolutionarily conserved.
Genes Dev. 23, 1910–1928.
Cooper, A.F., Yu, K.P., Brueckner, M., Brailey, L.L., Johnson, L., McGrath,
J.M., and Bale, A.E. (2005). Cardiac and CNS defects in a mouse with targeted
disruption of suppressor of fused. Development 132, 4407–4417.
DeSouza, R.M., Jones, B.R., Lowis, S.P., and Kurian, K.M. (2014). Pediatric
medulloblastoma - update on molecular classification driving targeted thera-
pies. Front. Oncol. 4, 176.
Di Magno, L., Coni, S., Di Marcotullio, L., and Canettieri, G. (2015). Digging a
hole under Hedgehog: downstream inhibition as an emerging anticancer strat-
egy. Biochim. Biophys. Acta 1856, 62–72.
Gilbert, W.V., Zhou, K., Butler, T.K., and Doudna, J.A. (2007). Cap-indepen-
dent translation is required for starvation-induced differentiation in yeast.
Science 317, 1224–1227.
Greer, E.L., Oskoui, P.R., Banko, M.R., Maniar, J.M., Gygi, M.P., Gygi, S.P.,
and Brunet, A. (2007). The energy sensor AMP-activated protein kinase
directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem.
282, 30107–30119.
Humke, E.W., Dorn, K.V., Milenkovic, L., Scott, M.P., and Rohatgi, R.
(2010). The output of Hedgehog signaling is controlled by the dynamic as-
sociation between Suppressor of Fused and the Gli proteins. Genes Dev.
24, 670–682.
Jeter, J.M., and Alberts, D.S. (2012). Difluoromethylornithine: the proof is in the
polyamines. Cancer Prev. Res. (Phila.) 5, 1341–1344.
Kim, J.J., Gill, P.S., Rotin, L., van Eede, M., Henkelman, R.M., Hui, C.C., and
Rosenblum, N.D. (2011). Suppressor of fused controls mid-hindbrain
patterning and cerebellar morphogenesis via GLI3 repressor. J. Neurosci.
31, 1825–1836.
Kim, J., Aftab, B.T., Tang, J.Y., Kim, D., Lee, A.H., Rezaee, M., Kim, J., Chen,
B., King, E.M., Borodovsky, A., et al. (2013). Itraconazole and arsenic trioxide34 Developmental Cell 35, 21–35, October 12, 2015 ª2015 Elsevier Iinhibit Hedgehog pathway activation and tumor growth associated with ac-
quired resistance to smoothened antagonists. Cancer Cell 23, 23–34.
Kool, M., Korshunov, A., Remke, M., Jones, D.T., Schlanstein, M., Northcott,
P.A., Cho, Y.J., Koster, J., Schouten-van Meeteren, A., van Vuurden, D.,
et al. (2012). Molecular subgroups of medulloblastoma: an international
meta-analysis of transcriptome, genetic aberrations, and clinical data of
WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol.
123, 473–484.
Lee, Y., Kawagoe, R., Sasai, K., Li, Y., Russell, H.R., Curran, T., andMcKinnon,
P.J. (2007). Loss of suppressor-of-fused function promotes tumorigenesis.
Oncogene 26, 6442–6447.
Liang, J., and Mills, G.B. (2013). AMPK: a contextual oncogene or tumor sup-
pressor? Cancer Res. 73, 2929–2935.
Mastronuzzi, A., Miele, E., Po, A., Antonelli, M., Buttarelli, F.R., Colafati, G.S.,
del Bufalo, F., Faedda, R., Spinelli, G.P., Carai, A., et al. (2014). Large cell
anaplastic medulloblastoma metastatic to the scalp: tumor and derived
stem-like cells features. BMC Cancer 14, 262.
Miele, E., Mastronuzzi, A., Po, A., Carai, A., Alfano, V., Serra, A., Colafati, G.S.,
Strocchio, L., Antonelli, M., Buttarelli, F.R., et al. (2015). Characterization of
medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene
and SHH molecular subgroup. Biomark. Res. 3, 13.
Nilsson, J.A., Keller, U.B., Baudino, T.A., Yang, C., Norton, S., Old, J.A.,
Nilsson, L.M., Neale, G., Kramer, D.L., Porter, C.W., and Cleveland, J.L.
(2005). Targeting ornithine decarboxylase in Myc-induced lymphomagenesis
prevents tumor formation. Cancer Cell 7, 433–444.
Northcott, P.A., Jones, D.T., Kool, M., Robinson, G.W., Gilbertson, R.J., Cho,
Y.J., Pomeroy, S.L., Korshunov, A., Lichter, P., Taylor, M.D., and Pfister, S.M.
(2012a). Medulloblastomics: the end of the beginning. Nat. Rev. Cancer 12,
818–834.
Northcott, P.A., Shih, D.J., Remke, M., Cho, Y.J., Kool, M., Hawkins, C.,
Eberhart, C.G., Dubuc, A., Guettouche, T., Cardentey, Y., et al. (2012b).
Rapid, reliable, and reproducible molecular sub-grouping of clinical medullo-
blastoma samples. Acta Neuropathol. 123, 615–626.
Passariello, C.L., Gottardi, D., Cetrullo, S., Zini, M., Campana, G., Tantini, B.,
Pignatti, C., Flamigni, F., Guarnieri, C., Caldarera, C.M., and Stefanelli, C.
(2012). Evidence that AMP-activated protein kinase can negatively modulate
ornithine decarboxylase activity in cardiac myoblasts. Biochim. Biophys.
Acta 1823, 800–807.
Pugh, T.J., Weeraratne, S.D., Archer, T.C., Pomeranz Krummel, D.A., Auclair,
D., Bochicchio, J., Carneiro, M.O., Carter, S.L., Cibulskis, K., Erlich, R.L., et al.
(2012). Medulloblastoma exome sequencing uncovers subtype-specific so-
matic mutations. Nature 488, 106–110.
Pyronnet, S., Pradayrol, L., and Sonenberg, N. (2000). A cell cycle-dependent
internal ribosome entry site. Mol. Cell 5, 607–616.
Robinson, G., Parker, M., Kranenburg, T.A., Lu, C., Chen, X., Ding, L., Phoenix,
T.N., Hedlund, E., Wei, L., Zhu, X., et al. (2012). Novel mutations target distinct
subgroups of medulloblastoma. Nature 488, 43–48.
Rounbehler, R.J., Li, W., Hall, M.A., Yang, C., Fallahi, M., and Cleveland, J.L.
(2009). Targeting ornithine decarboxylase impairs development of MYCN-
amplified neuroblastoma. Cancer Res. 69, 547–553.
Ryan, K.E., and Chiang, C. (2012). Hedgehog secretion and signal transduc-
tion in vertebrates. J. Biol. Chem. 287, 17905–17913.
Sammons, M.A., Antons, A.K., Bendjennat, M., Udd, B., Krahe, R., and Link,
A.J. (2010). ZNF9 activation of IRES-mediated translation of the human ODC
mRNA is decreased in myotonic dystrophy type 2. PLoS ONE 5, e9301.
Scalabrino, G., Modena, D., Ferioli, M.E., Puerari, M., and Luccarelli, G. (1982).
Degrees of malignancy in human primary central nervous system tumors: orni-
thine decarboxylase levels as better indicators than adenosylmethionine de-
carboxylase levels. J. Natl. Cancer Inst. 68, 751–754.
Schroeder, K., and Gururangan, S. (2014). Molecular variants andmutations in
medulloblastoma. Pharm. Genomics Pers. Med. 7, 43–51.
Schu¨ller, U., Heine, V.M., Mao, J., Kho, A.T., Dillon, A.K., Han, Y.G., Huillard,
E., Sun, T., Ligon, A.H., Qian, Y., et al. (2008). Acquisition of granule neuronnc.
precursor identity is a critical determinant of progenitor cell competence to
form Shh-induced medulloblastoma. Cancer Cell 14, 123–134.
Shantz, L.M., and Levin, V.A. (2007). Regulation of ornithine decarboxylase
during oncogenic transformation: mechanisms and therapeutic potential.
Amino Acids 33, 213–223.
Spriggs, K.A., Stoneley, M., Bushell, M., and Willis, A.E. (2008). Re-program-
ming of translation following cell stress allows IRES-mediated translation to
predominate. Biol. Cell 100, 27–38.
Sva¨rd, J., Heby-Henricson, K., Persson-Lek, M., Rozell, B., Lauth, M.,
Bergstro¨m, A., Ericson, J., Toftga˚rd, R., and Teglund, S. (2006). Genetic elim-
ination of Suppressor of fused reveals an essential repressor function in the
mammalian Hedgehog signaling pathway. Dev. Cell 10, 187–197.
Tang, X., Kim, A.L., Feith, D.J., Pegg, A.E., Russo, J., Zhang, H., Aszterbaum,
M., Kopelovich, L., Epstein, E.H., Jr., Bickers, D.R., and Athar, M. (2004).
Ornithine decarboxylase is a target for chemoprevention of basal and squa-
mous cell carcinomas in Ptch1+/- mice. J. Clin. Invest. 113, 867–875.
Tavladoraki, P., Cona, A., Federico, R., Tempera,G., Viceconte, N., Saccoccio,
S., Battaglia, V., Toninello, A., and Agostinelli, E. (2012). Polyamine catabolism:Devetarget for antiproliferative therapies in animals and stress tolerance strategies
in plants. Amino Acids 42, 411–426.
Teperino, R., Amann, S., Bayer, M., McGee, S.L., Loipetzberger, A., Connor,
T., Jaeger, C., Kammerer, B., Winter, L., Wiche, G., et al. (2012). Hedgehog
partial agonism drives Warburg-like metabolism in muscle and brown fat.
Cell 151, 414–426.
Wang, C., Pan, Y., and Wang, B. (2010). Suppressor of fused and Spop regu-
late the stability, processing and function of Gli2 and Gli3 full-length activators
but not their repressors. Development 137, 2001–2009.
Wechsler-Reya, R.J., and Scott, M.P. (1999). Control of neuronal precursor
proliferation in the cerebellum by Sonic Hedgehog. Neuron 22, 103–114.
Wu, X., Northcott, P.A., Croul, S., and Taylor, M.D. (2011). Mouse models of
medulloblastoma. Chin. J. Cancer 30, 442–449.
Yang, Z.J., Ellis, T., Markant, S.L., Read, T.A., Kessler, J.D., Bourboulas, M.,
Schu¨ller, U., Machold, R., Fishell, G., Rowitch, D.H., et al. (2008).
Medulloblastoma can be initiated by deletion of Patched in lineage-restricted
progenitors or stem cells. Cancer Cell 14, 135–145.lopmental Cell 35, 21–35, October 12, 2015 ª2015 Elsevier Inc. 35
